Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novo Nordisk A/S    NOVO B   DK0060534915

Delayed Quote. Delayed  - 08/23 04:59:44 pm
312.2 DKK   -0.70%
08/22 NOVO NORDISK A/ : Helicopter View of A Sustainable City
08/22 NOVO NORDISK A/ : - Share repurchase programme
08/15 NOVO NORDISK A/ : - Share repurchase programme
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Copenhagen
08/17/2016 08/18/2016 08/19/2016 08/22/2016 08/23/2016 Date
309.3(c) 309.5(c) 308.7(c) 314.4(c) 312.2(c) Last
2 669 451 3 101 547 2 251 165 3 504 235 2 671 743 Volume
-0.16% +0.06% -0.26% +1.85% -0.70% Change
More quotes
Financials ( DKK)
Sales 2016 113 807 M
EBIT 2016 49 524 M
Net income 2016 38 583 M
Finance 2016 14 222 M
Yield 2016 2,30%
Sales 2017 121 348 M
EBIT 2017 52 929 M
Net income 2017 41 758 M
Finance 2017 16 438 M
Yield 2017 2,53%
P/E ratio 2016 20,48
P/E ratio 2017 18,61
EV / Sales2016 5,40x
EV / Sales2017 5,04x
Capitalization 628 322 M
More Financials
Company
Novo Nordisk AS engages in the research, development, manufacture, and marketing of pharmaceutical products.It operates through the Diabetes and Obesity Care; and Biopharmaceuticals segments.The Diabetes and Obesity Care segment covers insulins, glucagon-like-peptide 1, other protein-related... 
Sector
Pharmaceuticals
Calendar
08/30Presentation
More about the company
Surperformance© ratings of Novo Nordisk A/S
Trading Rating : Investor Rating :
More Ratings
Latest news on NOVO NORDISK A/S
08/22 NOVO NORDISK A/S : Helicopter View of A Sustainable City
08/22 NOVO NORDISK A/S : - Share repurchase programme
08/15 NOVO NORDISK A/S : - Share repurchase programme
08/12 NOVO NORDISK A/S : ex-dividend day for interim dividend
08/11 NOVO NORDISK A/S : Report Summarizes Type 2 Diabetes Study Findings from Novo No..
08/09 NOVO NORDISK A/S : NHS Scotland approves Novo Nordisk's diabetes drug
08/08 NOVO NORDISK A/S : increased adjusted operating profit by 8% in local currencies..
08/05 CAVERION : Delivers a Large Project for Novo Nordisks New Insulin Production Fac..
08/05 NOVO NORDISK A/S : #WeAreNotWaiting
08/05 NOVO NORDISK A/S : beats 2Q profit forecasts
More news
Sector news : Pharmaceuticals - NEC
08:20a ASTRAZENECA : to sell antibiotics business to Pfizer
08/23DJU.S. Lawmakers Plan Hearing Over Wave of Agriculture Mergers
08/23DJPFIZER : to Acquire Key Drug -- WSJ
08/23DJDeal for Medivation Is the Latest In a Line of Similar Acquisitions -- WSJ
08/23DJNew CFO Tops Off Shake-Up At Valeant -- WSJ
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
08/22 Novo Nordisk Vs. Oramed - A Second Look At The Battle For Oral Insulin
08/19 Play Oncology To Play M&A In Big Pharma?
08/18 The Battle For Oral Insulin
08/16 Biotechnology Dogs Move Big Pharma Off Healthcare Top Slots In August
08/15 NOVO NORDISK : Don't Be Fooled; This Stock Only Goes Up On Better-Than-Expected ..
Advertisement
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO B | DK0060534915 | 4-Traders
Full-screen chart
Technical analysis trends NOVO NORDISK A/S
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 31
Average target price 378  DKK
Spread / Average Target 21%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Lars Rebien Sørensen President & Chief Executive Officer
Göran Albert Ando Chairman
Jesper Brandgaard Chief Financial Officer & Executive Vice President
Mads Krogsgaard Thomsen Chief Science Officer & Executive Vice President
Alan C. Moses Global Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
NOVO NORDISK A/S-21.38%95 337
JOHNSON & JOHNSON16.28%326 773
ROCHE HOLDING LTD.-12.26%219 257
NOVARTIS AG-9.97%214 603
PFIZER INC.8.71%212 844
MERCK & CO., INC.20.37%175 812
More Results